Audit 56673

FY End
2022-06-30
Total Expended
$323.48M
Findings
2
Programs
103
Year: 2022 Accepted: 2022-12-19

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
61391 2022-001 - - L
637833 2022-001 - - L

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $114.94M Yes 1
93.RD Open Targets Data Prep $3.79M Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $2.01M Yes 0
84.305 Education Research, Development and Dissemination $1.45M Yes 0
93.103 Food and Drug Administration_research $1.33M Yes 0
93.354 Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response $1.11M Yes 0
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $864,596 Yes 0
93.397 Cancer Centers Support Grants $678,062 Yes 0
93.225 National Research Service Awards_health Services Research Training $670,425 Yes 0
93.253 Poison Center Support and Enhancement Grant $533,139 - 0
93.RD Targeted Clinical Research to Address Select-Viral Infections $487,573 Yes 0
93.RD Develop Recombinant Aav Vectors $430,287 - 0
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $427,944 Yes 0
20.600 State and Community Highway Safety $417,506 - 0
93.398 Cancer Research Manpower $393,089 Yes 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nations Health $353,902 Yes 0
93.RD Biomedical Advanced Research and Development Authority $297,166 Yes 0
93.361 Nursing Research $291,071 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $285,907 Yes 0
93.233 National Center on Sleep Disorders Research $231,441 Yes 0
93.396 Cancer Biology Research $210,966 Yes 0
93.RD Covid-19 Multisystem Inflammatory Syndrome in Children (mis-C) Pilot Project $209,157 Yes 0
93.877 Autism Collaboration, Accountability, Research, Education, and Support $206,751 Yes 0
93.732 Mental and Behavioral Health Education and Training Grants $186,861 Yes 0
10.001 Agricultural Research_basic and Applied Research $185,311 - 0
93.558 Temporary Assistance for Needy Families $175,361 - 0
12.420 Military Medical Research and Development $174,853 Yes 0
93.087 Enhance Safety of Children Affected by Substance Abuse $174,792 Yes 0
93.838 Lung Diseases Research $159,763 Yes 0
93.945 Assistance Programs for Chronic Disease Prevention and Control $154,936 Yes 0
16.575 Crime Victim Assistance $146,872 - 0
93.991 Preventive Health and Health Services Block Grant $145,446 - 0
93.127 Emergency Medical Services for Children $139,028 - 0
12.431 Basic Scientific Research $127,780 Yes 0
93.317 Emerging Infections Programs $124,542 - 0
93.RD Pediatric High-Risk Cancer Preclinical Model Resource $124,321 Yes 0
93.RD Incidence and Outcomes of Human Adenovirus Infection $123,307 Yes 0
93.600 Head Start $119,518 - 0
93.395 Cancer Treatment Research $111,535 Yes 0
93.855 Allergy, Immunology and Transplantation Research $104,085 Yes 0
93.273 Alcohol Research Programs $91,551 Yes 0
93.307 Minority Health and Health Disparities Research $80,296 Yes 0
43.003 Exploration $79,050 Yes 0
93.940 Hiv Prevention Activities_health Department Based $77,853 - 0
93.865 Child Health and Human Development Extramural Research $77,128 Yes 0
93.RD Indian Health Service $77,126 Yes 0
93.RD Chronic Disease and Injury Prevention $72,264 Yes 0
93.279 Drug Abuse and Addiction Research Programs $70,535 Yes 0
93.393 Cancer Cause and Prevention Research $67,740 Yes 0
93.242 Mental Health Research Grants $65,177 Yes 0
93.917 Hiv Care Formula Grants $65,000 - 0
93.283 Centers for Disease Control and Prevention_investigations and Technical Assistance $62,013 - 0
93.914 Hiv Emergency Relief Project Grants $59,857 - 0
93.350 National Center for Advancing Translational Sciences $54,277 Yes 0
93.994 Maternal and Child Health Services Block Grant to the States $53,160 - 0
93.939 Hiv Prevention Activities_non-Governmental Organization Based $48,504 - 0
93.680 Medical Student Education $45,660 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $44,897 Yes 0
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $42,776 - 0
93.173 Research Related to Deafness and Communication Disorders $37,957 Yes 0
93.RD Office of the National Coordinator for Health Information Technology $37,309 Yes 0
47.070 Computer and Information Science and Engineering $36,190 Yes 0
93.121 Oral Diseases and Disorders Research $32,783 Yes 0
93.879 Medical Library Assistance $32,415 Yes 0
93.321 Dietary Supplement Research Program $30,931 Yes 0
93.217 Family Planning_services $30,370 - 0
93.113 Environmental Health $29,163 Yes 0
93.839 Blood Diseases and Resources Research $26,910 Yes 0
93.070 Environmental Public Health and Emergency Response $24,344 - 0
93.RD Active Risk Identification and Analysis $23,665 Yes 0
21.027 Coronavirus State and Local Fiscal Recovery Funds $22,894 - 0
93.394 Cancer Detection and Diagnosis Research $21,094 Yes 0
93.RD (ptn) Core Function Activties $20,375 Yes 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $18,332 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $17,574 Yes 0
93.837 Cardiovascular Diseases Research $17,369 Yes 0
93.866 Aging Research $16,846 Yes 0
93.084 Prevention of Disease, Disability, and Death by Infectious Diseases $16,200 Yes 0
47.041 Engineering $12,989 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $12,857 Yes 0
93.865 Cardiovascular Diseases Research $12,602 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $12,327 Yes 0
93.686 Ending the Hiv Epidemic: A Plan for America Ryan White Hiv/aids Program Parts A and B (b) $11,223 - 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $10,472 Yes 0
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $10,431 Yes 0
16.560 National Institute of Justice Research, Evaluation, and Development Project Grants $9,496 - 0
10.310 Agriculture and Food Research Initiative (afri) $9,144 - 0
93.213 Research and Training in Complementary and Integrative Health $8,911 Yes 0
47.075 Social, Behavioral, and Economic Sciences $7,810 Yes 0
93.RD Polyethylene Glycol Safety in Children $7,371 Yes 0
93.RD Pumps for Kids, Infants and Neonates (pumpkin) Clinical Trial $7,217 Yes 0
93.RD Patholgy Studies $6,715 Yes 0
93.859 Biomedical Research and Research Training $3,491 Yes 0
20.200 Highway Research and Development Program $1,254 - 0
93.989 International Research and Research Training $26 Yes 0
93.867 Vision Research $18 Yes 0
66.034 Surveys, Studies, Research, Investigations, Demonstrations, and Special Purpose Activities Relating to the Clean Air Act $2 Yes 0
93.399 Cancer Control $-340 Yes 0
93.310 Trans-Nih Research Support $-1,655 Yes 0
93.351 Research Infrastructure Programs $-6,094 Yes 0
93.365 Sickle Cell Treatment Demonstration Program $-10,416 Yes 0
93.928 Special Projects of National Significance $-21,238 - 0
93.172 Human Genome Research $-29,784 Yes 0

Contacts

Name Title Type
G7MQPLSUX1L4 Bethann Kurek Auditee
2673192401 Kelly Thornton Auditor
No contacts on file

Notes to SEFA

Title: Department of Health and Human Services Provider Relief Funds Accounting Policies: Basis of PresentationThe accompanying Schedule of Expenditures of Federal Awards, Schedule of Expenditures of State Awards, and Supplemental Statements of Program Expenditures and Program Revenues (the Schedules), which include the Federal and State of New Jersey grant transactions of The Childrens Hospital of Philadelphia Foundation and Controlled Affiliates (the Enterprise), and the federal funds passed through the City of Philadelphia, are recorded on the cash basis of accounting, which is a comprehensive basis of accounting other than accounting principles generally accepted in the United States of America. Because the Schedules present only a selected portion of the operations of the Enterprise, they are not intended to and do not present the financial position, changes in net assets or cash flows of the Enterprise. The information in these Schedules is presented in accordance with the requirements of Government Auditing Standards, issued by the Comptroller General of the United States; and the audit requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), the State of New Jersey Single Audit Policy Circular Letter 15-08-OMB.Negative amounts represent adjustments or credits to amounts reported as expenditures in prior years. The pass-through ID numbers were noted in the Schedule of Expenditures of Federal Awards when available. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. Expenditures consist of direct costs and indirect costs. The Enterprise applies its predetermined approved facilities and administration rate when charging indirect costs to federal awards rather than the 10% de minimis cost rate as described in Section 200.414 of the Uniform Guidance. The Enterprise was the recipient of funding under Assistance Listing 93.498, Department of Health and Human Services (HHS) Coronavirus Aid Relief and Economic Security (CARES) Act Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution (PRF). The grant activity presented in the Schedule of Expenditures of Federal awards associated with this Assistance Listing includes all Period 2 and Period 3 funding received between July 1, 2020 and June 30, 2021 as reported to HRSA via the PRF Reporting Portal and includes lost revenues and direct expenditures. The Schedule of Expenditures of Federal Awards includes $114,972,688 of Provider Relief Funds received that have been covered by $23,098 of direct expenditures and $114,949,590 of lost revenues. Business NameEINPayments plus interest Received Lost RevenuesDirect ExpendituresChildrens Hospital of Philadelphia23-1352166$105,204,807$105,181,709$23,098*Childrens Health Care Associates of NJ, PC23-3036699$4,714,033$4,714,033$0 Childrens Radiology Associates of New Jersey, P.C.81-1626790$44,830$44,830$0Childrens Surgical Associates, Ltd.23-2589322$190,500$190,500$0Childrens Anesthesiology Assoc Ltd23-2592835$3,975,414$3,975,414$0Childrens Anesthesiology Assoc of NJ22-3405673$266,992$266,992$0Radiology Associates of Childrens Hospital, Inc.23-2665855$576,112$576,112$0Totals$114,972,688$114,949,590$23,098*Total expenses actually reported in the Period 2 reporting portal submission were $2,355,345. See finding 2022-001

Finding Details

Award Year: January 1, 2020 to December 31, 2021 Pass-through: Not applicable Criteria Step Four of the Steps on Reporting on Use of Funds section of the June 11, 2021 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution (PRF) General and Targeted Distribution Post-Payment Notice of Reporting Requirements requires recipients to report on expenses paid for which payments were received through the General and Targeted Distribution payments. Reporting Entities that received $500,000 or more in aggregated PRF payments during each Payment Received Period are required to report on the use of the General and Other Targeted PRF payments in detailed categories of General and Administrative Expenses and Health Care-Related Expenses, by indicating the quarterly expenses reimbursed with the PRF payments. Condition The Company reported total Health Care-Related Expenses of $2,355,345 (for calendar quarters Q1 2020 and Q2 2020) in the PRF Reporting Portal Submission for Period 1 for The Children?s Hospital of Philadelphia. The Company duplicated the reporting of these expenses (for calendar quarters Q1 2020 and Q2 2020) in the PRF Reporting Portal Submission for Period 2 for the same entity. Cause The Company did not interpret the HRSA PRF Reporting instructions correctly, thereby duplicating the reporting of the Other PRF Expenses of $2,355,345 in both the Period 1 and Period 2 PRF Reporting Portal Submissions. Effect The duplicate reporting of expenses in the PRF Portal Submission for Period 1 and Period 2 resulted in an incorrect calculation of the Total Reportable Other PRF remaining to be applied to Lost Revenues amount in the PRF Financial Summary section of the PRF Portal Submission for Period 2. The calculated amount of PRF Remaining to be applied to Lost Revenues in the PRF Portal Submission for Period 2 was calculated as $102,826,364 whereas the amount would have been $105,181,709 if the expenses had not been duplicated in the Period 2 PRF Portal Submission Reporting. The total amount of PRF payments utilized in the period did not change, however, the amounts reported as Health Care-Related Expenses and PRF applied to Lost Revenues for the period were overstated and understated, respectively, by the $2,355,345 noted above. Questioned Costs None noted as the Company had sufficient lost revenue to apply against the provider relief funding received. Recommendation We recommend the Company contact the Health Resources and Services Administration to determine any required corrective actions related to the incorrect reporting.Management?s Views and Corrective Action Plan Management?s views and corrective action plan is included at the end of this report after the summary schedule of prior audit findings and status.
Award Year: January 1, 2020 to December 31, 2021 Pass-through: Not applicable Criteria Step Four of the Steps on Reporting on Use of Funds section of the June 11, 2021 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution (PRF) General and Targeted Distribution Post-Payment Notice of Reporting Requirements requires recipients to report on expenses paid for which payments were received through the General and Targeted Distribution payments. Reporting Entities that received $500,000 or more in aggregated PRF payments during each Payment Received Period are required to report on the use of the General and Other Targeted PRF payments in detailed categories of General and Administrative Expenses and Health Care-Related Expenses, by indicating the quarterly expenses reimbursed with the PRF payments. Condition The Company reported total Health Care-Related Expenses of $2,355,345 (for calendar quarters Q1 2020 and Q2 2020) in the PRF Reporting Portal Submission for Period 1 for The Children?s Hospital of Philadelphia. The Company duplicated the reporting of these expenses (for calendar quarters Q1 2020 and Q2 2020) in the PRF Reporting Portal Submission for Period 2 for the same entity. Cause The Company did not interpret the HRSA PRF Reporting instructions correctly, thereby duplicating the reporting of the Other PRF Expenses of $2,355,345 in both the Period 1 and Period 2 PRF Reporting Portal Submissions. Effect The duplicate reporting of expenses in the PRF Portal Submission for Period 1 and Period 2 resulted in an incorrect calculation of the Total Reportable Other PRF remaining to be applied to Lost Revenues amount in the PRF Financial Summary section of the PRF Portal Submission for Period 2. The calculated amount of PRF Remaining to be applied to Lost Revenues in the PRF Portal Submission for Period 2 was calculated as $102,826,364 whereas the amount would have been $105,181,709 if the expenses had not been duplicated in the Period 2 PRF Portal Submission Reporting. The total amount of PRF payments utilized in the period did not change, however, the amounts reported as Health Care-Related Expenses and PRF applied to Lost Revenues for the period were overstated and understated, respectively, by the $2,355,345 noted above. Questioned Costs None noted as the Company had sufficient lost revenue to apply against the provider relief funding received. Recommendation We recommend the Company contact the Health Resources and Services Administration to determine any required corrective actions related to the incorrect reporting.Management?s Views and Corrective Action Plan Management?s views and corrective action plan is included at the end of this report after the summary schedule of prior audit findings and status.